Dr James McCormack public
[search 0]
More

Download the App!

show episodes
 
The Best Science (BS) Medicine Podcast is a weekly presentation where practitioners can get evidence-based drug therapy content that is practical, entertaining and promotes healthy scepticism. In essence, we are the Medication Mythbusters. We present information that is useful and relevant to physicians, pharmacists, nurses, physician assistants and other health professionals, and that can easily be incorporated into day-to-day practice. The podcast is presented by Dr. James McCormack, Profe ...
 
Loading …
show series
 
In episode 469, Mike and James continue their discussion about misinterpretation and misdirection and how much of it starts with a narrative/story. We bring up a number of specific “stories” that are examples of how we were initially mislead into making bad treatment decisions.By JPM
 
In episode 467, Mike and James finish off talking with Jamie Falk about COPD/inhalers. We go over the some of the latest trials for the triple therapies and then wrap up all the evidence into a nice package and put a bow on it.At the end we finally get to the issue of eosinophils and let you know if you need to know this number.Show notes…
 
In episode 466, Mike and James continue talking with Jamie Falk about everything COPD/inhalers. We go over the evidence for the steroid component of inhalers and then we start going over the triple therapies. But all Mike really wants to talk about are eosinophils – but that is PART III.Show notesBy JPM
 
In episode 463, James and Mike talk about the latest reports of the results of the 2 COVID-19 vaccine trials. We give you all the numbers you need to know and maybe more importantly we discuss the nuances around industry bias, the approval process and general thoughts around vaccines in these crazy times.Show notes…
 
In episode 462, James and Mike invite Scott Garrison to talk about some important nuances around guideline recommendations and how low we should lower systolic blood pressure. We look in detail at the SPRINT trial and then come up with a reasonable (in our minds) approach to what thresholds we should use.Show notes…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login